Methods and pharmaceutical compositions for treating down syndrome

Details for Australian Patent Application No. 2010298440 (hide)

Owner Neuronascent, Inc

Inventors Kelleher-Andersson, Judith

Agent Peter Maxwell & Associates

Pub. Number AU-A-2010298440

PCT Pub. Number WO2011/037962

Priority 61/244,851 22.09.09 US

Filing date 22 September 2010

Wipo publication date 31 March 2011

International Classifications

A61K 31/47 (2006.01) - Quinolines

A61K 31/275 (2006.01) - Nitriles

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

Event Publications

12 April 2012 PCT application entered the National Phase

  PCT publication WO2011/037962 Priority application(s): WO2011/037962

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010298445-Reducing aluminosilicate scale in the bayer process

2010298437-Novel polymorphs of rebaudioside C and methods for making and using the same